RxDoctor Payments Data

Timothy Damrow, DO

Family Medicine · Manteno, ILNPI 1225418981

Payments from drug & device makers

$9,965in general payments, 2019–2025

Across 587 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Novo Nordisk$1K
  • AbbVie$1K
  • Lilly USA, LLC$859
  • Boehringer Ingelheim$820
  • Amgen$390
  • plus $4K from 35 others

What the payments were for

  • Food & beverage$9,965100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,965 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$130,476
Medicare patients
300
Services billed
1,763

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide50$61,877
JardianceEmpagliflozin42$50,506
FarxigaDapagliflozin Propanediol37$47,974
OzempicSemaglutide27$27,231
Trelegy ElliptaFluticasone/Umeclidin/Vilanter35$24,059
EliquisApixaban21$17,659
VraylarCariprazine Hcl13$16,090
Spiriva HandihalerTiotropium Bromide18$8,963
JanuviaSitagliptin Phosphate13$8,395
Breo ElliptaFluticasone/Vilanterol15$5,996
Lantus SolostarInsulin Glargine,hum.Rec.Anlog37$5,135
Atorvastatin Calcium457$4,215
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate23$4,102
Albuterol Sulfate HfaAlbuterol Sulfate141$4,003
Gabapentin167$3,669

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$859$61,87750 claims
Boehringer IngelheimJardiance$820$50,50642 claims
AstraZenecaFarxiga$1,480$47,97437 claims
GSKTrelegy Ellipta, Breo Ellipta$228$30,05550 claims
Novo NordiskOzempic$1,367$27,23127 claims
PfizerEliquis$338$17,65921 claims
AbbVieVraylar, Synthroid$1,270$17,38027 claims
MerckJanuvia$274$8,39513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Manteno

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →